INMED PHARMACEUTICALS INC. Basic Shares Outstanding (Weighted Average)
INMED PHARMACEUTICALS INC. (INM) reported Basic Shares Outstanding (Weighted Average) of 4.16 million shares for the 12-month period ending 2026-06-30, per its S-4/A filed 2026-09-09.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-09-09
- INMED PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 4.70M shares, a 214.94% increase year-over-year.
- INMED PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 4.05M shares, a 269.37% increase year-over-year.
- INMED PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 3.95M shares, a 459.70% increase year-over-year.
- INMED PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 3.95M shares, a 537.70% increase year-over-year.
- INMED PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for fiscal 2023 was 2.45M shares, a 336.58% increase from fiscal 2022.
- INMED PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for fiscal 2022 was 560.83K shares, a 108.65% increase from fiscal 2021.
- INMED PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for fiscal 2021 was 268.79K shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 4.70M shares derived: S-4/A 12 month − S-4 9 month · filed 2026-09-09 | 4.37M shares derived: average of 2 quarters · filed 2026-09-09 | 4.23M shares derived: average of 3 quarters · filed 2026-09-09 | 4.16M shares S-4/A · filed 2026-09-09 | |||
| 2026-03-31 | 4.05M shares S-4 · filed 2026-07-02 | 4.00M shares derived: average of 2 quarters · filed 2026-07-02 | 3.99M shares S-4 · filed 2026-07-02 | 3.36M shares derived: average of 4 quarters · filed 2026-09-09 | |||
| 2025-12-31 | 3.95M shares 10-Q · filed 2026-02-11 | 3.95M shares 10-Q · filed 2026-02-11 | 3.13M shares derived: average of 3 quarters · filed 2026-09-09 | 2.62M shares derived: average of 4 quarters · filed 2026-09-09 | |||
| 2025-09-30 | 3.95M shares 10-Q · filed 2025-11-06 | 2.72M shares derived: average of 2 quarters · filed 2026-09-09 | 2.18M shares derived: average of 3 quarters · filed 2026-09-09 | 1.81M shares derived: average of 4 quarters · filed 2026-09-09 | |||
| 2025-06-30 | 1.49M shares derived: S-4/A 12 month − S-4 9 month · filed 2026-09-09 | 1.29M shares derived: average of 2 quarters · filed 2026-09-09 | 1.10M shares derived: average of 3 quarters · filed 2026-09-09 | 975.89K shares S-4/A · filed 2026-09-09 | 975.99K shares 10-K · filed 2025-09-23 | ||
| 2025-03-31 | 1.10M shares S-4 · filed 2026-07-02 | 901.26K shares derived: average of 2 quarters · filed 2026-07-02 | 803.91K shares S-4 · filed 2026-07-02 | 725.64K shares derived: average of 4 quarters · filed 2026-07-02 | |||
| 2024-12-31 | 706.55K shares 10-Q · filed 2026-02-11 | 661.05K shares 10-Q · filed 2026-02-11 | 602.20K shares derived: average of 3 quarters · filed 2026-07-02 | 571.81K shares derived: average of 4 quarters · filed 2026-07-02 | |||
| 2024-09-30 | 620.13K shares 10-Q · filed 2025-11-06 | 550.02K shares derived: average of 2 quarters · filed 2026-07-02 | 526.90K shares derived: average of 3 quarters · filed 2026-07-02 | 494.84K shares derived: average of 4 quarters · filed 2026-07-02 | |||
| 2024-06-30 | 479.92K shares derived: S-4 12 month − 10-Q 9 month · filed 2026-07-02 | 480.29K shares derived: average of 2 quarters · filed 2026-07-02 | 453.08K shares derived: average of 3 quarters · filed 2026-07-02 | 381.05K shares S-4 · filed 2026-07-02 | 7.62M shares 10-K · filed 2024-09-30 | ||
| 2024-03-31 | 480.65K shares 10-Q · filed 2025-05-12 | 439.66K shares derived: average of 2 quarters · filed 2025-05-12 | 348.10K shares 10-Q · filed 2025-05-12 | 1.09M shares derived: average of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | 398.67K shares 10-Q · filed 2025-02-12 | 7.97M shares 10-Q · filed 2024-02-13 | 282.54K shares 10-Q · filed 2025-02-12 | 5.65M shares 10-Q · filed 2024-02-13 | 1.30M shares derived: average of 3 quarters · filed 2025-02-12 | 1.80M shares derived: average of 4 quarters · filed 2025-02-12 | |
| 2023-09-30 | 166.41K shares 10-Q · filed 2024-11-14 | 3.33M shares 10-Q · filed 2023-11-14 | 1.75M shares derived: average of 2 quarters · filed 2024-11-14 | 2.27M shares derived: average of 3 quarters · filed 2024-11-14 | 2.28M shares derived: average of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | 3.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | 3.33M shares derived: average of 2 quarters · filed 2024-09-30 | 2.98M shares derived: average of 3 quarters · filed 2024-09-30 | 2.45M shares 10-K · filed 2024-09-30 | |||
| 2023-03-31 | 3.33M shares 10-Q · filed 2023-05-15 | 2.81M shares derived: average of 2 quarters · filed 2024-02-13 | 2.16M shares 10-Q · filed 2023-05-15 | 1.78M shares derived: average of 4 quarters · filed 2024-02-13 | |||
| 2022-12-31 | 2.30M shares 10-Q · filed 2024-02-13 | 1.58M shares 10-Q · filed 2024-02-13 | 1.27M shares derived: average of 3 quarters · filed 2024-02-13 | 1.09M shares derived: average of 4 quarters · filed 2024-02-13 | |||
| 2022-09-30 | 865.62K shares 10-Q · filed 2023-11-14 | 754.86K shares derived: average of 2 quarters · filed 2023-11-14 | 691.93K shares derived: average of 3 quarters · filed 2023-11-14 | 657.42K shares derived: average of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | 644.11K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-29 | 605.08K shares derived: average of 2 quarters · filed 2023-09-29 | 588.02K shares derived: average of 3 quarters · filed 2023-09-29 | 560.83K shares 10-K · filed 2023-09-29 | |||
| 2022-03-31 | 566.06K shares 10-Q · filed 2023-05-15 | 559.98K shares derived: average of 2 quarters · filed 2023-05-15 | 533.07K shares 10-Q · filed 2023-05-15 | ||||
| 2021-12-31 | 553.89K shares 10-Q · filed 2023-02-17 | 516.93K shares 10-Q · filed 2023-02-17 | |||||
| 2021-09-30 | 481.90K shares 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | 268.79K shares 10-K · filed 2022-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |